Trial Profile
Safety and tolerability of rigosertib in adult patients with advanced solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Nov 2015
Price :
$35
*
At a glance
- Drugs Rigosertib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 19 Nov 2015 New trial record